Catalyst Wire Dossier Catalyst Wire Dossier

RVX-100

· Revogenex, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RVX-100, covering 2010-07-19 to 2010-07-19. Get the full timeline:

Most recent: Clinical Trial Update: A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D) [Phase 2]

See pricing